Emunkitug

N/A

Report date: 2025/12/25 15:59:38
First In Class

Base Information

Drug NameEmunkitug
Drug Alias NameHFB-2003HFB-200301
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B agonists
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsSkin MelanomaSolid tumoursNeoplasm Metastasis +[14
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpainMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHiFiBiO Therapeutics
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSkin MelanomaSolid tumoursNeoplasm Metastasis +[13
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A